4-methyl-6-methoxy-8-nitro-5-quinoline | 82333-37-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-methyl-6-methoxy-8-nitro-5-quinoline
• 英文别名: 6-methoxy-4-methyl-8-nitro-5-<3-(trifluoromethyl)phenoxy>quinoline；6-methoxy-4-methyl-8-nitro-5-(3-trifluoromethylphenyloxy)quinoline；4-methyl-5-(3-trifluoromethylphenoxy)-6-methoxy-8-nitroquinoline；4-Methyl-5-[3-trifluoromethylphenoxy]-6-methoxy-8-nitroquinoline；6-methoxy-4-methyl-8-nitro-5-[3-(trifluoromethyl)phenoxy]quinoline
• CAS: 82333-37-7
• 化学式: C₁₈H₁₃F₃N₂O₄
• 分子量: 378.307
• InChiKey: HEVJIRFVOSZRJC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  27
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  77.2
• 氢给体数：
  0
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  4-methyl-6-methoxy-8-nitro-5-quinoline 在 镍 ligroin 作用下， 以 ethanol-dioxane 为溶剂， 反应 4.0h， 以to afford 4.1 g (76%) of the title compound mp 113°-115°的产率得到8-amino-6-methoxy-4-methyl-5-(3-trifluoromethylphenoxy)quinoline
  参考文献：
  名称：

  4-Methyl-5-(unsubstituted and substituted

  摘要：

  本类化合物包括4-甲基-5-(未取代和取代的苯氧基)-6-甲氧基-8-(氨基烷基)喹啉作为自由碱和药学上可接受的酸胺盐。这些化合物是高效的抗疟疾药物，出人意料地具有组织无性红体杀灭（根治性）和血液无性红体杀灭（抑制性）活性。此外，这些药物的治疗指数显著优于目前组织无性红体杀灭药物首选的前奎宁。在可耐受的剂量水平下，前奎宁没有有用的血液无性红体杀灭活性。

  公开号：

  US04431807A1
• 作为产物：
  描述：

  4'-甲氧基乙酰苯胺 在 盐酸 、 磷酸 、 水 、 溴 、 硝酸 、 砷酸、原砷酸 作用下， 以 乙醇 、 乙酸酐 、 溶剂黄146 、 N,N-二甲基甲酰胺 为溶剂， 反应 42.33h， 生成 4-methyl-6-methoxy-8-nitro-5-quinoline
  参考文献：
  名称：

  WO2007/127930

  摘要：

  公开号：

文献信息

• 4-Methyl-5-(unsubstituted and substituted
  申请人：The United States of America as represented by the Secretary of the Army

  公开号：US04431807A1

  公开（公告）日：1984-02-14

  Compounds of the class including 4-methyl-5-(unsubstituted and substituted henoxy)-6-methoxy-8-(aminoalkylamino)quinolines as the free bases and pharmaceutically acceptable acid amine salts are described. The compounds are highly effective antimalarial agents which possess, surprisingly, both tissue schizonticidal (radical curative) and blood schizonticidal (suppressive) activity. In addition, these drugs have significantly better therapeutics indices than primaquine which is the current tissue schizonticidal drug of choice. Primaquine possesses no useful blood schizonticidal activity at tolerated dose levels.

  该类化合物包括4-甲基-5-（未取代和取代henoxy）-6-甲氧基-8-（氨基烷基氨基）喹啉作为自由碱和药学上可接受的酸胺盐。这些化合物是高效的抗疟疾药物，令人惊讶的是，它们具有组织红细胞分裂体杀灭（根治性）和血液红细胞分裂体杀灭（抑制性）活性。此外，这些药物的治疗指数显著优于普利昂奎，后者是目前组织红细胞分裂体杀灭药物的首选药物。普利昂奎在可耐受的剂量水平下没有有用的血液红细胞分裂体杀灭活性。
• 4-methyl-5-(unsubstituted and substituted
  申请人：The United States of America as represented by the Secretary of the Army

  公开号：US04617394A1

  公开（公告）日：1986-10-14

  Compounds of the class including 4-methyl-5-(unsubstituted and substituted phenoxy)-2,6-dimethoxy-8-(aminoalkylamino)quinolines as the free bases and pharmaceutically acceptable acid amine salts are described. The compounds are highly effective antimalarial agents which possess both tissue schizonticidal (radical curative) and blood schizonticidal (suppressive) acitivity. In addition, these drugs have significantly better therapeutic indices than primaquine which is the current tissue schizonticidal drug of choice. Primaquine possesses no useful blood schizonticidal activity at tolerated dose levels. The new 2-methoxy substituted compounds produce markedly less methemoglobin at effective dose levels and thus permit a higher degree of safety than analogs which are unsubstituted in the 2-position.

  本类化合物包括4-甲基-5-（未取代和取代的苯氧基）-2,6-二甲氧基-8-（氨基烷基氨基）喹啉作为自由碱和药学上可接受的酸胺盐。这些化合物是高效的抗疟疾药物，具有组织无性繁殖体杀灭（根治）和血液无性繁殖体杀灭（抑制）活性。此外，这些药物的治疗指数显著优于目前选择的组织无性繁殖体杀灭药物-盐酸伯氨喹。在可耐受的剂量水平下，盐酸伯氨喹没有有用的血液无性繁殖体杀灭活性。新的2-甲氧基取代化合物在有效剂量水平下产生的甲血红蛋白明显较少，因此比2-位未取代的类似物具有更高的安全性。
• COMPOUNDS AFFECTING GAP JUNCTION ACTIVITY
  申请人：HUA Duy H.

  公开号：US20090143425A1

  公开（公告）日：2009-06-04

  This invention relates to novel quinoline compounds which affect gap junction activity. Also provided are methods of using such compounds and compositions containing the compounds to treat gap junction disorders.

  本发明涉及新型喹啉化合物，其影响间隙连接活性。还提供了使用这种化合物的方法和含有这种化合物的组合物来治疗间隙连接障碍。
• Synthesis and anti-breast cancer activities of substituted quinolines
  作者：Aibin Shi、Thu A. Nguyen、Srinivas K. Battina、Sandeep Rana、Dolores J. Takemoto、Peter K. Chiang、Duy H. Hua

  DOI：10.1016/j.bmcl.2008.04.024

  日期：2008.6

  Promising anti-breast cancer agents derived from substituted quinolines were discovered. The quinolines were readily synthesized in a large scale from a sequence of reactions starting from 4-acetamidoanisole. The Michael addition product was isolated as the reaction intermediate in the ring closing reaction of 4-amino-5-nitro-2-(3-trifluoromethylphenyloxy) anisole with methyl vinyl ketone leading to 6-methoxy-4-methyl-8-nitro-5-(3-trifluoromethylphenyloxy) quinoline (14). The amino function of 8-amino-6-methoxy-4- methyl-5-(3-trifluoromethylphenyloxy) quinoline, prepared from 14, was connected to various side chains via alkylation with N( 3-iodopropyl) phthalimide, Michael addition with acrylonitrile, and reductive amination with various heterocycle carboxaldehydes, such as imidazole-4-carboxaldehyde, thiophene-2-carboxaldehyde, and 2-furaldehyde. Effects of the substituted quinolines on cell viability of T47D breast cancer cells using trypan blue exclusion assay were examined. The results showed that the IC50 value of 6-methoxy-8-[(2-furanylmethyl) amino]-4-methyl-5-(3-trifluoromethylphenyloxy) quinoline is 16 +/- 3 nM, the lowest IC50 out of all the quinolines tested. IC50 values of three other quinolines are in the nanomolar range, a desirable range for pharmacological testing. (C) 2008 Elsevier Ltd. All rights reserved.
• Antimalarials. 14. 5-(Aryloxy)-4-methylprimaquine analogs. A highly effective series of blood and tissue schizonticidal agents
  作者：Maurice P. LaMontagne、Peter Blumbergs、Richard E. Strube

  DOI：10.1021/jm00351a017

  日期：1982.9

  A series of five 5-(aryloxy)-4-methylprimaquine analogues has been prepared and evaluated for antimalarial activity. The compounds were tested for suppressive activity against Plasmodium berghei in mice and for radical curative activity against Plasmodium cynomolgi in the rhesus monkey. The compounds were not only significantly superior to primaquine as radical curative agents but also were suprisingly highly effective as suppressive agents.